- Home
- COEP vs RENB Comparison
COEP vs RENB Comparison
Compare COEP & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- RENB
- Stock Information
- Founded
- COEP 2017
- RENB 2011
- Country
- COEP United States
- RENB United States
- Employees
- COEP N/A
- RENB N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- COEP Health Care
- RENB Health Care
- Exchange
- COEP Nasdaq
- RENB Nasdaq
- Market Cap
- COEP 62.4M
- RENB 57.7M
- IPO Year
- COEP N/A
- RENB N/A
- Fundamental
- Price
- COEP $12.96
- RENB $0.19
- Analyst Decision
- COEP
- RENB
- Analyst Count
- COEP 0
- RENB 0
- Target Price
- COEP N/A
- RENB N/A
- AVG Volume (30 Days)
- COEP 45.5K
- RENB 896.6K
- Earning Date
- COEP 11-12-2025
- RENB 11-13-2025
- Dividend Yield
- COEP N/A
- RENB N/A
- EPS Growth
- COEP N/A
- RENB N/A
- EPS
- COEP N/A
- RENB N/A
- Revenue
- COEP $263,555.00
- RENB N/A
- Revenue This Year
- COEP N/A
- RENB N/A
- Revenue Next Year
- COEP N/A
- RENB N/A
- P/E Ratio
- COEP N/A
- RENB N/A
- Revenue Growth
- COEP N/A
- RENB N/A
- 52 Week Low
- COEP $2.31
- RENB $0.18
- 52 Week High
- COEP $14.70
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- COEP 54.10
- RENB 37.01
- Support Level
- COEP $12.09
- RENB $0.18
- Resistance Level
- COEP $13.53
- RENB $0.22
- Average True Range (ATR)
- COEP 0.74
- RENB 0.02
- MACD
- COEP -0.12
- RENB -0.00
- Stochastic Oscillator
- COEP 56.55
- RENB 13.73
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.